Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 known ✓ | P35372 | 6/20 | 0.49 |
| ▸ | HTR2A known ✓ | P28223 | 4/20 | 0.44 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.49 |
| ▸ | CCR5 | P51681 | 6/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL10322983 | 0.96 | OPRM1 (0.51) | OPRM1TMEM97CCR5HTR2A | |
| SCHEMBL342207 | 0.94 | OPRM1 (0.52) | OPRM1TMEM97CCR5HTR2A | |
| Cadaverine Tartrate SCHEMBL10323301 | 0.92 | OPRM1 (0.48) | OPRM1TMEM97CCR5HTR2A | |
| Cadaverine Tartrate SCHEMBL10322706 | 0.92 | CCR5 (0.48) | OPRM1TMEM97CCR5HTR2A | |
| Cadaverine Tartrate SCHEMBL10323019 | 0.92 | OPRM1 (0.47) | OPRM1TMEM97CCR5HTR2A | |
| Cadaverine Tartrate SCHEMBL10322063 | 0.92 | OPRM1 (0.47) | OPRM1TMEM97CCR5HTR2A | |
| Cadaverine Tartrate SCHEMBL10322794 | 0.91 | OPRM1 (0.50) | OPRM1TMEM97CCR5HTR2A | |
| Cadaverine Tartrate SCHEMBL10320325 | 0.90 | OPRM1 (0.45) | OPRM1TMEM97CCR5HTR2A | |
| SCHEMBL340417 | 0.89 | OPRM1 (0.54) | OPRM1TMEM97CCR5HTR2A | |
| Cadaverine Tartrate SCHEMBL10321820 | 0.89 | OPRM1 (0.49) | OPRM1TMEM97CCR5HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140350064-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONERGIC AGENT AND METHODS OF USE THEREOF | ALS MOUNTAIN LLC | 2014-11-27 | — | — | US | claimed |
| US-20120183600-A1 | NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME AND OTHER CONDITIONS | CHEN CHIEN-HUNG (US) | 2012-07-19 | — | — | US | claimed |
| US-20140350064-A1 | PHARMACEUTICAL COMPOSITION COMPRISING AN AMPK ACTIVATOR AND A SEROTONERGIC AGENT AND METHODS OF USE THEREOF | ALS MOUNTAIN LLC | 2014-11-27 | — | — | US | disclosed |
| US-20120183600-A1 | NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME AND OTHER CONDITIONS | CHEN CHIEN-HUNG (US) | 2012-07-19 | — | — | US | disclosed |